Legal Representation
Attorney
Steven E. Lauridsen
USPTO Deadlines
Next Deadline
1743 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241119)
Due Date
November 19, 2030
Grace Period Ends
May 19, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 19, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Nov 19, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Sep 3, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 3, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 14, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 1, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 27, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 27, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 26, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 28, 2024 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Jan 25, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 6, 2023 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Aug 21, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 25, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Media for cell culture for research use in the biotechnological industry, all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
Class 005
Biotechnological immune cell preparations for medical use, all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer; media for cell culture for medical use in the biotechnological industry, all of the aforesaid being for use in cell therapy, living cell therapy and the treatment of cancer
Class 042
Biotechnological research; Research relating to biotechnology; Research and development in the field of biotechnology; Research and development in the pharmaceutical and biotechnology fields; all of the aforesaid relating to cell therapy, living cell therapy and the treatment of cancer
Classification
International Classes
001
005
042